Jeevan Scientific Technology Ltd Share Price Today - Jeevan Scientific Technology Ltd Stock Price Live NSE/BSE

Jeevan Scientific Technology Ltd

NSE: BSE: 538837

₹62

(-2.99%)

Sat, 14 Mar 2026, 04:11 am

MTF 5xInvest in Jeevan Scientific Technology Ltd with 5x Leverage Buy with MTF

Market Cap1.27B

PE Ratio0

Dividend0

Health Services

Medical/Nursing Services

24.5K

Jeevan Scientific Technology Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
119.27
Net Profit
0.06
P/B
1.27
Sector P/E
55.74
P/E
501.25
EV/EBITDA
10.32
Debt/Equity (Industry)
0.58
Interest Cover (Industry)
3.46
ROCE (Industry)
5.19
RONW (Industry)
4.39
ROE
0.14
ROCE
2.79
Debt/Equity
0.35
EPS (TTM)
0
Dividend Yield
0
Book Value
31.90
Interest Cover
1.02

Analysis

all

Pros

Jeevan Scientific Technology is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Jeevan Scientific Technology has been profitable on average in the past, therefore cash runway is not a concern.
Jeevan Scientific Technology has been profitable on average in the past, therefore cash runway is not a concern.
Debt is covered by short term assets, assets are 1.4x debt.
Jeevan Scientific Technology's cash and other short term assets cover its long term commitments.

Cons

Unable to evaluate Jeevan Scientific Technology's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Jeevan Scientific Technology's dividend against the top 25% market benchmark as the company has not reported any payouts.
Debt is not well covered by operating cash flow (18.6%, less than 20% of total debt).
Jeevan Scientific Technology's level of debt (63.1%) compared to net worth is high (greater than 40%).
High level of physical assets or inventory.

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	38.05	38.05	38.05	38.05	37.84
FII	0	0	0	0	0
DII	0	0	0	0	0
Public	61.95	61.95	61.95	61.95	62.16
Government	0	0	0	0	0

Technical Analysis

RSI

35.13

MACD

-1.14

50 DMA

66.49

200 DMA

52.32

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	88.97	78.38	73.66	67.79	63.07	57.20	46.61
Fibonacci	78.38	74.33	71.83	67.79	63.74	61.24	57.20
Camarilla	71.86	70.89	69.92	67.79	67.98	67.01	66.04

Pivots Level: Classic

+21.18

88.97

+10.59

78.38

+5.88

73.66

67.79

Pivot Point

LTP: 59.88

-4.71

63.07

-10.59

57.20

-21.18

46.61

Moving Average

SMAEMA

Period

Value

10-EMA
64.44
20-EMA
65.86
30-EMA
66.08
50-EMA
65.45
100-EMA
62.05
200-EMA
56.80

Announcement Date	Purpose	Action	Ex Date
15 Oct 2025	egm
08 Sept 2025	agm
01 Mar 2025	egm
30 May 2024	agm
14 Aug 2023	agm
27 Mar 2023	egm
11 Nov 2022	egm
12 Aug 2022	agm
30 May 2022	dividend	₹1.20 Dividend /Share	23 Sept 2022
25 Mar 2022	egm

Jeevan Scientific Technology Ltd

Apollo Hospitals Enterprise Ltd

Max Healthcare Institute Ltd

Narayana Hrudayalaya Ltd

Fortis Healthcare Ltd

Aster DM Healthcare Ltd

Jeevan Scientific Technology Ltd About

Jeevan Scientific Tech. is to carry on the business Clinical research, Data management services. Jeevan Scientific is an Independent Clinical Contract Research Organization, offering reliable, cost-effective and technology-driven clinical research solutions to various Clients across the globe.

Industry

Miscellaneous

Founded

1999

Headquarters

CEO

Divakar Atluri

Employees

Contact

Website

http://www.jeevanscientific.com

info@jeevanscientific.com

Phone

91-40-67364700

Location

Plot 1 & 2 Sai Krupa Enclave, Manikonda Jagir Nr Lanco Hills, Hyderabad, Telangana, 500008

Year	History
2015	Acquired Bioanalytical Facility from Directorate General of Health Services Office of Drug Controller General Conducted a Workshop on Pharmacokinetics and Biostatistics Attended the 8th International Annual Conference on Translational Clinical Pharmacology Research in Drug Development in Mumbai Established a new IT Division Registered with USFDA as Self-identified site following GDUFA 2012 act Formed ENHOPS Solutions Pvt Ltd, a wholly owned subsidiary company Participated in CPHI worldwide conference at Spain Participated in CPHI conference at India
2016	Amendment to the Memorandum of Association of the Company was made The Company's Clinical Pharmacology Centre was approved by the Office of Drug Control General, India
2017	Successfully completed our First USFDA inspection to Bioanalytical facility with no 483
2019	Reached mark of 200 studies in a span of 2 years from the date of initiation of our first full scope BE study in Feb 2017
2020	Jeevan Scientific has established an exceptional and complex service portfolio of GLUCOSE CLAMPING TECHNIQUE PHASE I UNIT

Client Name	Order Side	QTY	Avg Price	Date
DURISALA DESAIAH	Sell	500000	52.16	15 Oct 2025
RAMPURHAT PSC SLEEPERS LIMITED	Buy	115000	52.94	15 Oct 2025
SHEETAL SHARMA	Buy	90000	52	15 Oct 2025
PRITY AGARWAL	Buy	300000	50.3	13 Oct 2025
RAMPURHAT PSC SLEEPERS LIMITED	Buy	100000	49.97	13 Oct 2025
NANDELA GOPALAKRISHNA REDDY	Sell	500000	50.2	13 Oct 2025
AKSHAT JAJODIA	Buy	100000	50.48	13 Oct 2025
VIJAY KUMAR PAHWA	Buy	77010	90.46	30 Jun 2021
ALPHA LEON ENTERPRISES LLP	Sell	86051	96.38	22 Jun 2021
ALPHA LEON ENTERPRISES LLP	Buy	86051	88.9	22 Jun 2021

Jeevan Scientific Technology Ltd News

Jeevan Scientific Gets US FDA Assessment Report

Jeevan Scientific Technology Limited receives US FDA Remote Regulatory Assessment Report following review of its Hyderabad clinical pharmacology facility from October-November 2025.

22 Jan 2026

stocks

Jeevan Scientific Promoters Acquire 30L Warrants

Multiple promoters of Jeevan Scientific Technology acquired 30,00,000 convertible warrants through preferential allotment on January 2, with Krishna Kishore Kuchipudi leading with 12,00,000 warrants.

06 Jan 2026

co actions results

Jeevan Scientific Acquires Naya Pharma for ₹10 Cr

Jeevan Scientific Technology announces acquisition of 60% stake in Naya Pharma Private Limited for ₹10 crores, funded through preferential issue proceeds approved in November 2025.

18 Dec 2025

co actions results

Jeevan Scientific Technology Limited Shareholders Approve All Four Resolutions in Extraordinary General Meeting

Jeevan Scientific Technology Limited held an Extraordinary General Meeting on November 12, 2025, through video conferencing from 10:00 AM to 10:40 AM. The meeting had 58 members in attendance out of 5,436 total shareholders on record date. All four proposed resolutions were passed with requisite majority: adoption of Memorandum of Association as per Companies Act 2013, increase in authorized share capital and consequent alteration of capital clause, issue of convertible warrants on preferential basis to promoters and non-promoters for cash consideration, and issue of equity shares on preferential basis to non-promoters for cash consideration. The voting was conducted through remote e-voting (November 9-11, 2025) and electronic voting during the meeting. AakankshaSachin Dubey served as the scrutinizer for the voting process.

12 Nov 2025

corporate action

Jeevan Scientific Technology Reports Quarterly Results for September 2025

Jeevan Scientific Technology Limited announced its unaudited financial results for the quarter and half year ended September 30, 2025. The Board of Directors approved both standalone and consolidated financial statements during their meeting held on November 12, 2025. The company's standalone cash flows show a net loss before tax of ₹268.56 lakhs for the half year ended September 30, 2025, compared to a profit of ₹77.05 lakhs for the year ended March 31, 2025. On a consolidated basis, the net loss before tax was ₹369.90 lakhs for the half year ended September 30, 2025, versus a profit of ₹5.07 lakhs for the year ended March 31, 2025. The consolidated results include subsidiary Nayas Laboratories Private Limited, which reported total revenues of ₹194.18 lakhs and net profit after tax of ₹9.50 lakhs for the quarter ended September 30, 2025.

12 Nov 2025

earnings

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800